Article Details

Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease ...

Retrieved on: 2021-09-07 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease .... View article details on HISWAI: https://www.fiercebiotech.com/biotech/roche-hoping-to-move-from-recent-failure-pens-190m-neuexcell-huntington-s-disease-pact

Excerpt

Back in March, Roche had to stop a phase 3 Huntington's disease test after ... It is technically Roche's Spark unit, the gene therapy biotech it bought out ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up